Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
GLOBE
1 other identifier
observational
500
1 country
1
Brief Summary
We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 13, 2025
CompletedFirst Posted
Study publicly available on registry
November 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
November 14, 2025
November 1, 2025
8 months
November 13, 2025
November 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Development of a Disease-Specific Questionnaire
2 months
Secondary Outcomes (1)
Quality of Life Instrument
2 months
Other Outcomes (1)
Cost Implications of Obesity
2 months
Eligibility Criteria
Patients with BMI over 25 Healthcare professionals treating patients.
You may qualify if:
- Patient group
- Patient is aged ≥18 years at the time of survey completion.
- Patient has a BMI over 25 (self-reported)
- Patient is willing to participate in all study activities.
- Patient is able to read, write, and converse in English.
- HCP is aged ≥18 years at the time of survey completion.
- HCP is suitably qualified and involved in the healthcare management of patients with a BMI over 25
- HCP is willing to participate in all study activities.
- HCP is able to read, write, and converse in English.
You may not qualify if:
- A participant who meets any of the following criteria will be excluded from the study:
- Participants do not have the cognitive capacity to provide informed consent.
- Participants with severe co-morbidity that might affect study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medialis Ltd.lead
Study Sites (1)
Online recruitment
Milton Keynes, MK12 5NW, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 60 Months
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
November 13, 2025
First Posted
November 14, 2025
Study Start
November 1, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
November 14, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share